Trip (John) Anderson

Program: Ph.D. Biomolecular Pharmacology/ Biogen
Advisor: Hui Feng, Ph.D.
Research Summary: Trip is interested in identifying a specific inhibitor that will inhibit the production of replication-competent JC virus by targeting the binding of VP2/VP3 to the VP1 pentamer. He is interested in cell biology, virology, drug discovery, and imaging.